（本節(jié)目所用的音頻資源發(fā)表于2022年9月上旬。）

英國(guó)牛津大學(xué)的科學(xué)家們已經(jīng)研發(fā)出一種有望 “改變世界” 的瘧疾疫苗。該團(tuán)隊(duì)表示，初期試驗(yàn)結(jié)果顯示此疫苗對(duì)瘧疾有80%的保護(hù)，他們希望能在明年推出此疫苗。

It looks increasingly likely that Oxford University's malaria jab is the real deal. A highly effective vaccine with the potential to save millions of lives in the coming years.

牛津大學(xué)研發(fā)的瘧疾疫苗看上去似乎有可能成為一個(gè)對(duì)抗瘧疾真正有效的疫苗。這是一種高效疫苗，有望在未來(lái)幾年挽救數(shù)百萬(wàn)人的生命。

Trials in West Africa involving 450 children had already shown that three doses of the vaccine gave around 75 per cent protection for a year. New results show that a booster dose at 12 months extends protection for a second year, at up to 80 per cent.

在西非進(jìn)行的、由450名兒童參與的試驗(yàn)已表明，接種完三劑疫苗后一年內(nèi)的保護(hù)效力約為75%。新試驗(yàn)結(jié)果顯示，完成全程接種12個(gè)月后注射加強(qiáng)針，可將保護(hù)期延長(zhǎng)一年，疫苗的保護(hù)效力達(dá)80%。

We may not need to wait long for definitive results from larger trials. Scientists plan to submit data to the World Health Organisation within weeks, with a view to getting the vaccine approved.

我們可能不需要等待太久，就可以從更大規(guī)模的試驗(yàn)中獲得最終數(shù)據(jù)結(jié)果?？茖W(xué)家計(jì)劃在未來(lái)幾周內(nèi)向世界衛(wèi)生組織提交數(shù)據(jù)，這是為了讓疫苗獲得批準(zhǔn)。

The Oxford team has partnered with the Serum Institute in India – the world's biggest vaccine manufacturer – and says at least 100 million doses could be produced next year at low cost to make it accessible to many of the world's least developed countries.

牛津團(tuán)隊(duì)與世界上最大的疫苗制造商印度血清研究所合作，并表示明年至少可低成本生產(chǎn)1億劑疫苗，讓世界許多最不發(fā)達(dá)的國(guó)家都有機(jī)會(huì)用此疫苗對(duì)抗瘧疾。

詞匯表

jab 針劑
the real deal 真正有效的好東西
effective 有效的
doses 劑，劑量
booster 加強(qiáng)針
definitive 最終的，最完整可靠的
approved 被批準(zhǔn)的，獲批的
accessible 可得到的，容易獲取的

閱讀理解：請(qǐng)?jiān)谧x完上文后，回答下列問(wèn)題。

1. Where did trials for this malaria vaccine take place?

2. What was found to extend protection against malaria?

3. What type of country will one vaccine manufacturer make vaccines available to?

4. How many lives could this new malaria vaccine save?

答案  

1. Where did trials for this malaria vaccine take place?
Trials took place in West Africa.

2. What was found to extend protection against malaria?
New results show that a booster dose at 12 months extends protection for a second year, at up to 80 per cent.

3. What type of country will one vaccine manufacturer make vaccines available to?
The Oxford team has partnered with the Serum Institute will make vaccines available to the world's least developed countries.

4. How many lives could this new malaria vaccine save?
This new vaccine has the potential to save millions of lives in the coming years.